Zukela Ruzi

Publications

Citations

H-Index

2021

Active since

Affiliations

Xinjiang Technical Institute of Physics & Chemistry(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Samarkand State University named after Sharof Rashidov

Zukela Ruzi is an author at Xinjiang Technical Institute of Physics & Chemistry specializing in drug discovery, natural sciences, and medicinal chemistry.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryDerivativesPharmacotherapyDrug DevelopmentMolecular Docking

Publications per year

2021–2023

Publications

Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action

Zukela Ruzi, Khurshed Bozorov, Lifei Nie et al. · Biomedicine & Pharmacotherapy · 2022 · 34 citations · Full text

Synthesis and anticancer activity of ethyl 5‐amino‐1‐<i>N</i>‐substituted‐imidazole‐4‐carboxylate building blocks

Zukela Ruzi, Lifei Nie, Khurshed Bozorov et al. · Archiv der Pharmazie · 2021 · 22 citations

<scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity

Yan Zeng, Lifei Nie, Khurshed Bozorov et al. · Journal of Heterocyclic Chemistry · 2021 · 21 citations

Organic Chemistry, Pharmacotherapy, Heterocycle Chemistry +18

Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties

Zukela Ruzi, Khurshed Bozorov, Lifei Nie et al. · Bioorganic Chemistry · 2023 · 15 citations

Molecular Docking, Medicinal Chemistry, Ddr2 Kinase Inhibitor +10

Rows per page

1–4 of 4